Immucell Corp (ICCC) Reports Q2 EPS of $0.03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
ImmuCell Announces Results for Second Quarter of 2015
August 13, 2015 4:05 PM EDTPORTLAND, ME -- (Marketwired) -- 08/13/15 -- ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced financial results for its second quarter ended June 30, 2015.
2015 Second Quarter Financial Overview:
Total sales increased 27% to $1.96 million during second quarter 2015, compared to second quarter 2014;Sales of First Defense® increased 25% during... More